Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.1450
-0.0100 (-6.45%)
Jun 2, 2025, 12:55 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 64.94 million as of June 2, 2025. Its market cap has decreased by -21.62% in one year.
Market Cap
64.94M
Enterprise Value
50.95M
Revenue
16.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 64.94M, a decrease of -32.37%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 64.94M | -25.64% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 119.99B |
| Pro Medicus | 29.46B |
| Cochlear | 17.76B |
| Sonic Healthcare | 12.81B |
| Telix Pharmaceuticals | 8.82B |
| Ramsay Health Care | 8.80B |
| Ansell | 4.57B |
| Regis Healthcare | 2.46B |